Zobrazeno 1 - 10
of 505
pro vyhledávání: '"mRECIST"'
Autor:
Annarita Fanizzi, Annamaria Catino, Samantha Bove, Maria Colomba Comes, Michele Montrone, Angela Sicolo, Rahel Signorile, Pia Perrotti, Pamela Pizzutilo, Domenico Galetta, Raffaella Massafra
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionMalignant pleural mesothelioma (MPM) is a poor-prognosis disease. Owing to the recent availability of new therapeutic options, there is a need to better assess prognosis. The initial clinical response could represent a useful parameter.Me
Externí odkaz:
https://doaj.org/article/3b046e21ce07461792ec79d50f98d1aa
Autor:
Amitkumar J. Choudhari, Suyash Kulkarni, Nitin Sudhakar Shetty, Kunal Gala, Daksh Chandra, Akshay D. Baheti
Publikováno v:
Journal of Gastrointestinal and Abdominal Radiology, Vol 06, Iss 03, Pp 202-211 (2023)
Hepatocellular carcinoma (HCC) is a leading cause of morbidity and mortality worldwide, including in India. The incidence of HCC has been rising due to lifestyle diseases such as obesity, diabetes, non-alcoholic fatty liver disease (NAFLD), and alcoh
Externí odkaz:
https://doaj.org/article/1b339cfcd99a451e9506072866e49292
Autor:
Raja Shaikh, Brent R. Weil, Christopher B. Weldon, Nan Chen, Wendy B. London, Morgan Krush, Megan Anderson, Mark Gebhardt, Alanna J. Church, Steven G. DuBois, Yana Pikman, Jennifer Spidle, Catherine B. Wall, Angela Feraco, Nicole J. Ullrich, Jennifer W. Mack, Elizabeth Mullen, Junne Kamihara, Suzanne Forrest, Suzanne Shusterman, Katherine A. Janeway, Ahmad Alomari, Horacio Padua, Carlos Rodriguez‐Galindo, Allison F. O'Neill
Publikováno v:
Cancer Medicine, Vol 12, Iss 12, Pp 13300-13308 (2023)
Abstract Background Pediatric interventional oncology (PIO) is a growing field intended to provide additional or alternative treatment options for pediatric patients with benign or malignant tumors. Large series of patients treated uniformly and subj
Externí odkaz:
https://doaj.org/article/c80b0344ed624477a0354a19d3dcdca0
Publikováno v:
The Egyptian Journal of Radiology and Nuclear Medicine, Vol 54, Iss 1, Pp 1-9 (2023)
Abstract Background Our aim is to evaluate LI-RADS-TR algorithm and its ability to assess the viability of TACE-treated HCC. We prospectively evaluated 100 patients with known HCC, treated with TACE and came for follow-up to assess therapy response a
Externí odkaz:
https://doaj.org/article/3c201e8486324998a3a800bea3c18694
Autor:
Zhi-Wei Li, A-Hong Ren, Da-Wei Yang, Hui Xu, Jian Wei, Chun-Wang Yuan, Zhen-Chang Wang, Zheng-Han Yang
Publikováno v:
BMC Medical Imaging, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background We aimed to evaluate the value of using preoperative magnetic resonance imaging (MRI) features and clinical indicators to predict the early response of hepatocellular carcinoma (HCC) to transcatheter arterial chemoembolization (TA
Externí odkaz:
https://doaj.org/article/71441d848ba54ef7ad1ff7388eef9e70
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 9, Pp 1011-1027 (2022)
Antonella Cammarota,1,2 Valentina Zanuso,1,2 Tiziana Pressiani,2 Nicola Personeni,1,2,* Lorenza Rimassa1,2,* 1Department of Biomedical Sciences, Humanitas University, Milan, Pieve Emanuele, Italy; 2Medical Oncology and Hematology Unit, Humani
Externí odkaz:
https://doaj.org/article/d1e4ceca311f4251bfccf9b739265b1d
Autor:
Osman Öcal, Regina Schinner, Kerstin Schütte, Enrico N. de Toni, Christian Loewe, Otto van Delden, Vincent Vandecaveye, Bernhard Gebauer, Christoph J. Zech, Christian Sengel, Irene Bargellini, Antonio Gasbarrini, Bruno Sangro, Maciej Pech, Peter Malfertheiner, Jens Ricke, Max Seidensticker, for the SORAMIC study group
Publikováno v:
Cancer Imaging, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background The aim of this study was to explore the relationship between follow-up imaging characteristics and overall survival (OS) in advanced hepatocellular carcinoma (HCC) patients under sorafenib treatment. Methods Associations between
Externí odkaz:
https://doaj.org/article/971541f80cc14c379bd9083efd0fc4b4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.